Sachs Associates Healthcare Events 2022
As a supporter of Sachs Associates, Optimum is pleased to be able to offer a 10% discount on its brilliant events coming up in 2022.
Tag Archive for: biotech
Novo Seeds Provides Business Update on a Record Year – Building Exceptional Companies for Global Impact
Over US$ 550 million raised by portfolio companies in 2021 IO Biotech IPO on US NASDAQ Forendo Pharma acquired for nearly US$ 1 billion Muna launched with world-leading science to advance latest scientific breakthroughs in neuroscience Adcendo raised US$ 60 million Series A to deliver next-generation Antibody-Drug Conjugates Hemab raised US$ 50 million Series A to […]
AMSilk Partners with Mercedes-Benz to Present a Sustainable Bio-Based Product
The use of a biotechnology-based and certified-vegan silk-like fabric marks a first in the automotive sector Partnership with market leader underscores application potential of AMSilk’s technology AMSilk GmbH (“AMSilk”), a world leader in supplying innovative high-performance bio-based silk materials, today announces that it has entered a partnership with Mercedes-Benz, for the development of novel, sustainable […]
2021 and beyond with Destiny Pharma’s CEO, Neil Clark & CFO Shaun Claydon
Management of Destiny Pharma (DEST), the AIM listed infection prevention biotechnology company, offer an overview of the Company, their platform and their late stage clinical assets heading towards phase 3 trails. The team expand on the anti infective market, their COVID 19 program and the strength of their balance sheet. The Company finish with their […]
EXACT Therapeutics AS to present at DNB Nordic Healthcare Conference on 16th December 2021
OSLO/LONDON: 13 DECEMBER, 2021: EXACT Therapeutics AS (“EXACT-Tx”, or “the Company” Euronext Growth: EXTX), a clinical-stage precision health company evaluating Acoustic Cluster Therapy (ACT®) across multiple therapeutic areas, today announces that its Interim Chief Executive Officer and Chief Financial Officer, Dominic Moreland and Chief Medical Officer, Dr Hilary McElwaine-Johnn will present a corporate overview via […]
